u/milos_vanhecke

area% is not mass%, and here is exactly why it matters

Not convinced. The evidence does not support that reading.

phase 2 is not phase 3, smaller n and shorter trial

the 15-day half-life means week 15 is still ramp-up pharmacokinetically

axis labels included, always

post the whole document, not the headline number

Adding to this: COA is doing more work than the comment implies.

off-label use data is different from approved-indication data

incretin physiology is gastric emptying, the mechanism layer

Phase 2 TRIUMPH looked amazing. Phase 3 trials are harder. Do not anchor on phase 2 readouts.

glucagon-receptor contribution is incretin for dual and triple agonism

cite the paper: journal, year, first author, links optional

Batch number and date of analysis? Both are load-bearing.

PDF metadata is checkable in fifteen seconds

Water content on the document? That affects your concentration math.

Not to be pedantic but TRIUMPH and SURPASS are being used interchangeably and they are not interchangeable in real life.

Water content on the document? That affects your concentration math.

Disagree but this is the good kind of wrong — it is specific enough to be checked.

Metadata check caught a COA that was created in a browser four months after the analysis date. Not evidence of fraud, but worth flagging to JEEP.

phase 2 is not phase 3, smaller n and shorter trial

amylin is not GLP-1, posts conflating them get corrected